HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cushing's syndrome: a model for sarcopenic obesity.

AbstractPURPOSE:
Obesity and its metabolic impairments are discussed as major risk factors for sarcopenia leading to sarcopenic obesity. Cushing's syndrome is known to be associated with obesity and muscle atrophy. We compared Cushing's syndrome with matched obese controls regarding body composition, physical performance, and biochemical markers to test the hypothesis that Cushing's syndrome could be a model for sarcopenic obesity.
METHODS:
By propensity score matching, 47 controls were selected by body mass index and gender as obese controls. Fat mass and muscle mass were measured by bioelectrical impedance analysis. Muscle function was assessed by chair rising test and hand grip strength. Biochemical markers of glucose and lipid metabolism and inflammation (hsCRP) were measured in peripheral blood.
RESULTS:
Muscle mass did not differ between Cushing's syndrome and obese controls. However, Cushing's syndrome patients showed significantly greater chair rising time (9.5 s vs. 7.3 s, p = 0.008) and significantly lower hand grip strength (32.1 kg vs. 36.8 kg, p = 0.003). Cushing's syndrome patients with impaired fasting glucose have shown the highest limitations in hand grip strength and chair rising time.
CONCLUSIONS:
Similar to published data in ageing medicine, Cushing's syndrome patients show loss of muscle function that cannot be explained by loss of muscle mass. Impaired muscle quality due to fat infiltration may be the reason. This is supported by the observation that Cushing's syndrome patients with impaired glucose metabolism show strongest deterioration of muscle function. Research in sarcopenic obesity in elderly is hampered by confounding comorbidities and polypharmacy. As Cushing's syndrome patients are frequently free of comorbidities and as Cushing's syndrome is potentially curable we suggest Cushing's syndrome as a clinical model for further research in sarcopenic obesity.
AuthorsMichael Drey, Christina M Berr, Martin Reincke, Julia Fazel, Jochen Seissler, Jochen Schopohl, Martin Bidlingmaier, Stefanie Zopp, Nicole Reisch, Felix Beuschlein, Andrea Osswald, Ralf Schmidmaier
JournalEndocrine (Endocrine) Vol. 57 Issue 3 Pg. 481-485 (Sep 2017) ISSN: 1559-0100 [Electronic] United States
PMID28702888 (Publication Type: Comparative Study, Journal Article, Multicenter Study)
Chemical References
  • Biomarkers
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human
Topics
  • Adult
  • Biomarkers (blood)
  • Body Composition
  • Body Mass Index
  • Cushing Syndrome (blood, metabolism, physiopathology)
  • Female
  • Germany
  • Glucose Intolerance (etiology)
  • Glycated Hemoglobin (analysis)
  • Hand Strength
  • Humans
  • Insulin Resistance
  • Male
  • Matched-Pair Analysis
  • Middle Aged
  • Models, Biological
  • Muscle, Skeletal (physiopathology)
  • Obesity (blood, metabolism, physiopathology)
  • Propensity Score
  • Prospective Studies
  • Psychomotor Performance
  • Registries
  • Sarcopenia (etiology)
  • Waist-Height Ratio

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: